Actively Recruiting
Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations
Led by The University of Texas Health Science Center, Houston · Updated on 2024-07-15
270
Participants Needed
5
Research Sites
218 weeks
Total Duration
On this page
Sponsors
T
The University of Texas Health Science Center, Houston
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The PI and the research team developed the New York University (NYU) Electronic Patient Visit Assessment (ePVA) for head and neck cancer (HNC) as a patient-reported outcome measure (PRO) for the early detection of uncontrolled symptoms. The ePVA is digital patient-reported symptom monitoring system, providing actionable information at point-of-care that enables clinicians to provide real-time interventions. The study aims to advance the science of cancer care delivery by testing the effectiveness of the ePVA as a digital patient-reported monitoring system for patients with HNC in real-world settings and identify implementation strategies that optimize the effectiveness of the ePVA in diverse rural and urban settings. The study hypothesis is that participants assigned to the ePVA arm will have better swallowing, taste and smell, and social function than participants assigned to usual care arm at 4 weeks after completing radiation therapy.
CONDITIONS
Official Title
Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals with histologically diagnosed head and neck cancer undergoing curative radiation therapy with or without chemotherapy
- English or Spanish speaking
- Clinicians caring for patients with head and neck cancer at participating institutions
You will not qualify if you...
- Any medical condition that could limit the participant's ability to provide informed consent and complete the questionnaires
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
University of Kansas Cancer Center
Kansas City, Kansas, United States, 66160
Actively Recruiting
2
NYU Meyers College of Nursing
New York, New York, United States, 10010
Not Yet Recruiting
3
NYU Langone Perlmutter Cancer Center
New York, New York, United States, 10016
Actively Recruiting
4
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States, 19111
Not Yet Recruiting
5
UTHealth Houston Cizik School of Nursing
Houston, Texas, United States, 77030
Not Yet Recruiting
Research Team
J
Janet H. Van Cleave, PhD, RN
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here